Given the low incidence of SPS and limited reports on its concurrent occurrence with Hashimoto’s thyroiditis, along with decreased serum C3 complement levels, there may be a gap in the clinical understanding of SPS. This evidence concerns the gene C3 and Hashimoto thyroiditis.